Novocure (NASDAQ: NVCR) reported Q1 EPS of ($0.36), $0.06 better than the analyst estimate of ($0.42). Revenue for the quarter came in at $138.5 million versus the consensus estimate of $131.45 million.

For earnings history and earnings-related data on Novocure (NVCR) click here.